616 related articles for article (PubMed ID: 17712112)
21. Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity.
Wake DJ; Strand M; Rask E; Westerbacka J; Livingstone DE; Soderberg S; Andrew R; Yki-Jarvinen H; Olsson T; Walker BR
Clin Endocrinol (Oxf); 2007 Mar; 66(3):440-6. PubMed ID: 17302881
[TBL] [Abstract][Full Text] [Related]
22. Reduced cannabinoid receptor 1 protein in subcutaneous adipose tissue of obese.
Bennetzen MF; Nielsen TS; Paulsen SK; Bendix J; Fisker S; Jessen N; Lund S; Richelsen B; Pedersen SB
Eur J Clin Invest; 2010 Feb; 40(2):121-6. PubMed ID: 20039929
[TBL] [Abstract][Full Text] [Related]
23. 11beta-hydroxysteroid dehydrogenase type 1 is overexpressed in subcutaneous adipose tissue of morbidly obese patients.
Muñoz R; Carvajal C; Escalona A; Boza C; Pérez G; Ibáñez L; Fardella C
Obes Surg; 2009 Jun; 19(6):764-70. PubMed ID: 18592327
[TBL] [Abstract][Full Text] [Related]
24. Obesity is accompanied by disturbances in peripheral glucocorticoid metabolism and changes in FA recycling.
Simonyte K; Rask E; Näslund I; Angelhed JE; Lönn L; Olsson T; Mattsson C
Obesity (Silver Spring); 2009 Nov; 17(11):1982-7. PubMed ID: 19360009
[TBL] [Abstract][Full Text] [Related]
25. Effect of hyperlipidemia on 11β-hydroxysteroid-dehydrogenase, glucocorticoid receptor, and leptin expression in insulin-sensitive tissues of cats.
Sieber-Ruckstuhl NS; Zini E; Osto M; Franchini M; Boretti FS; Meli ML; Sigrist B; Lutz TA; Reusch CE
Domest Anim Endocrinol; 2010 Nov; 39(4):222-30. PubMed ID: 20688460
[TBL] [Abstract][Full Text] [Related]
26. Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue.
Mai K; Andres J; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
Clin Endocrinol (Oxf); 2007 Sep; 67(3):419-25. PubMed ID: 17555498
[TBL] [Abstract][Full Text] [Related]
27. Testosterone stimulates adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in a depot-specific manner in children.
Zhu L; Hou M; Sun B; Burén J; Zhang L; Yi J; Hernell O; Li X
J Clin Endocrinol Metab; 2010 Jul; 95(7):3300-8. PubMed ID: 20410225
[TBL] [Abstract][Full Text] [Related]
28. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
Livingstone DE; Walker BR
J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue.
Paulsen SK; Pedersen SB; Jørgensen JO; Fisker S; Christiansen JS; Flyvbjerg A; Richelsen B
J Clin Endocrinol Metab; 2006 Mar; 91(3):1093-8. PubMed ID: 16368752
[TBL] [Abstract][Full Text] [Related]
30. Regulation of 11β-HSD1 expression during adipose tissue expansion by hypoxia through different activities of NF-κB and HIF-1α.
Lee JH; Gao Z; Ye J
Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1035-41. PubMed ID: 23512810
[TBL] [Abstract][Full Text] [Related]
31. 11beta-hydroxysteroid dehydrogenase type 1 of the subcutaneous adipose tissue is dysregulated but not associated with metabolic disorders in adults born small for gestational age.
Meas T; Carreira E; Wang Y; Rauh M; Poitou C; Clément K; Dötsch J; Lévy-Marchal C
J Clin Endocrinol Metab; 2010 Aug; 95(8):3949-54. PubMed ID: 20519348
[TBL] [Abstract][Full Text] [Related]
32. Quantitative real-time PCR for the measurement of 11beta-HSD1 and 11beta-HSD2 mRNA levels in tissues of healthy dogs.
Sieber-Ruckstuhl NS; Meli ML; Boretti FS; Gönczi E; Lutz H; Reusch CE
Horm Metab Res; 2007 Aug; 39(8):548-54. PubMed ID: 17712718
[TBL] [Abstract][Full Text] [Related]
33. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
[TBL] [Abstract][Full Text] [Related]
34. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity.
Kolehmainen M; Vidal H; Alhava E; Uusitupa MI
Obes Res; 2001 Nov; 9(11):706-12. PubMed ID: 11707537
[TBL] [Abstract][Full Text] [Related]
35. Role of 11-beta-hydroxysteroid dehydrogenase type 1 in differentiation of 3T3-L1 cells and in rats with diet-induced obesity.
Liu Y; Sun WL; Sun Y; Hu G; Ding GX
Acta Pharmacol Sin; 2006 May; 27(5):588-96. PubMed ID: 16626514
[TBL] [Abstract][Full Text] [Related]
36. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
Stimson RH; Walker BR
Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
[TBL] [Abstract][Full Text] [Related]
37. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.
Tomlinson JW; Sinha B; Bujalska I; Hewison M; Stewart PM
J Clin Endocrinol Metab; 2002 Dec; 87(12):5630-5. PubMed ID: 12466364
[TBL] [Abstract][Full Text] [Related]
38. The expression of 11β-HSDs, GR, and H6PDH in subcutaneous adipose tissue from polycystic ovary syndrome subjects.
Li S; Tao T; Wang L; Mao X; Zheng J; Zhao A; Liu W
Horm Metab Res; 2013 Oct; 45(11):802-7. PubMed ID: 23979790
[TBL] [Abstract][Full Text] [Related]
39. 11-Hydroxy-β-steroid dehydrogenase gene expression in canine adipose tissue and adipocytes: stimulation by lipopolysaccharide and tumor necrosis factor α.
Ryan VH; Trayhurn P; Hunter L; Morris PJ; German AJ
Domest Anim Endocrinol; 2011 Oct; 41(3):150-61. PubMed ID: 21798686
[TBL] [Abstract][Full Text] [Related]
40. Human adipose tissue under in vitro inhibition of 11beta-hydroxysteroid dehydrogenase type 1: differentiation and metabolism changes.
Bader T; Zoumakis E; Friedberg M; Hiroi N; Chrousos GP; Hochberg Z
Horm Metab Res; 2002; 34(11-12):752-7. PubMed ID: 12660894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
